Martin Boeree is Associate Professor in lung diseases, especially tuberculosis and non-tuberculous mycobacteria. He studied medicine at the University of Groningen in the Netherlands and specialized as a pulmonologist at the University Medical Centre in the same town. He then went to Blantyre, Malawi in Africa to join the College of Medicine at the University of Malawi as a Senior Lecturer. He headed the Department of Medicine from 1996-2000. There, he built experience with the treatment and research of tuberculosis especially related to HIV. He served as advisor for the National TB Program. In 2000, he returned to the Netherlands where he joined the Department of Lung Diseases at the Radboud University Nijmegen Medical Centre. He was concurrently Director of the University Centre for Chronic Diseases and TB referral hospital Dekkerswald from 2005-2010. He was Chair for the Dutch Society of Tropical Medicine and the Federation of the European Societies of Tropical Medicine and International Health. He acts as one of the national consultants TB and NTM for KNCV Tuberculosis Foundation and the Dutch Thoracic Society. Martin Boeree has more than 150 publications focusing on drug treatment of tuberculosis and non-tuberculous mycobacterial infections. He was Chief Investigator of the HIGHRIF consortium within the PanACEA consortium focusing on the quest to find the “right” dose of rifampicine in its potential to shorten the duration of drug sensitive TB. He acts as Coordinator for the PanACEA II consortium.